GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Titan Medical Inc (FRA:QTNA) » Definitions » Cyclically Adjusted Price-to-FCF

Titan Medical (FRA:QTNA) Cyclically Adjusted Price-to-FCF : (As of Jun. 20, 2024)


View and export this data going back to . Start your Free Trial

What is Titan Medical Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Titan Medical Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Titan Medical's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Medical Cyclically Adjusted Price-to-FCF Chart

Titan Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Titan Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Titan Medical's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Titan Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Titan Medical's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Titan Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Titan Medical's Cyclically Adjusted Price-to-FCF falls into.



Titan Medical Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Titan Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Titan Medical's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.014/126.2576*126.2576
=-0.014

Current CPI (Mar. 2024) = 126.2576.

Titan Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.421 99.473 -0.534
201409 -1.057 99.394 -1.343
201412 -1.209 98.367 -1.552
201503 -1.779 99.789 -2.251
201506 -1.957 100.500 -2.459
201509 -2.565 100.421 -3.225
201512 -2.646 99.947 -3.343
201603 -3.927 101.054 -4.906
201606 -1.453 102.002 -1.799
201609 -1.174 101.765 -1.457
201612 -0.666 101.449 -0.829
201703 -0.693 102.634 -0.853
201706 -0.538 103.029 -0.659
201709 -0.574 103.345 -0.701
201712 -0.418 103.345 -0.511
201803 -0.363 105.004 -0.436
201806 -0.430 105.557 -0.514
201809 -0.525 105.636 -0.627
201812 -0.728 105.399 -0.872
201903 -0.734 106.979 -0.866
201906 -0.377 107.690 -0.442
201909 -0.377 107.611 -0.442
201912 -0.344 107.769 -0.403
202003 -0.052 107.927 -0.061
202006 0.090 108.401 0.105
202009 -0.050 108.164 -0.058
202012 -0.003 108.559 -0.003
202103 -0.116 110.298 -0.133
202106 -0.008 111.720 -0.009
202109 -0.081 112.905 -0.091
202112 -0.099 113.774 -0.110
202203 -0.017 117.646 -0.018
202206 -0.084 120.806 -0.088
202209 -0.076 120.648 -0.080
202212 -0.069 120.964 -0.072
202303 -0.016 122.702 -0.016
202306 0.061 124.203 0.062
202309 -0.013 125.230 -0.013
202312 -0.006 125.072 -0.006
202403 -0.014 126.258 -0.014

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Titan Medical  (FRA:QTNA) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Titan Medical Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Titan Medical's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Titan Medical (FRA:QTNA) Business Description

Traded in Other Exchanges
Address
76 Berkeley Street, Toronto, ON, CAN, M5A 2W7
Titan Medical Inc is in the research and development stage and is focused on the continued design and development of robotic-assisted surgical technologies for application in minimally invasive surgery including the development of the Enos robotic single-access surgical system.